Dorzolamide Hydrochloride Solution
Product Images NDC 68083-489

9 FDA label images from Gland Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride (NDC 68083-489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton-label (Carton Label)

Carton-label (Carton Label)
Unfolded packaging label for Dorzolamide Hydrochloride Ophthalmic Solution, USP 2% (20 mg/mL) sterile solution, 10 mL vial, labelled by Gland Pharma Limited. The label includes NDC 68083-489-01, instructions for topical eye application, preservative details, and storage instructions. Barcode and manufacturer details from Hyderabad, India, are shown.*
FDA Label Image

Container-label (Container Label)

Container-label (Container Label)
Dorzolamide Hydrochloride Ophthalmic Solution, USP 2% (20 mg/mL dorzolamide equivalent) in a 10 mL bottle. Label shows the NDC 68083-489-01 and states it is a sterile, prescription-only solution for topical application in the eye. Manufactured by Gland Pharma Limited, Hyderabad, India. Storage instructions specify 15°C to 30°C and protection from light.*
FDA Label Image

Figure-a (Figure A)

Figure-a (Figure A)
An instructional illustration depicting an ophthalmic solution bottle with labeled parts: a cap, a tamper evident ring just below the cap, and the bottle body. This diagram is related to Dorzolamide Hydrochloride 20 mg/mL ophthalmic solution by Gland Pharma Limited.*
FDA Label Image

Figure-b (Figure B)

Figure-b (Figure B)
An instructional diagram showing two hands holding and opening a small ophthalmic solution bottle with a dropper cap. This figure likely illustrates how to remove or twist off the cap from the bottle of Dorzolamide Hydrochloride ophthalmic solution.*
FDA Label Image

Figure-c (Figure C)

Figure-c (Figure C)
An instructional diagram illustrating how to remove or open the cap of a bottle. The image shows a dropper bottle with an arrow indicating the direction to twist the cap for removal.*
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
An instructional line drawing showing a hand applying an ophthalmic solution to the eye by gently pulling down the lower eyelid to create a pocket for the eye drop.*
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
Illustration showing the proper technique to administer ophthalmic solution eye drops. The image depicts a hand holding a dropper bottle above an open eye with a drop about to be released, emphasizing correct positioning for eye drop instillation.*
FDA Label Image

Figure-f (Figure F)

Figure-f (Figure F)
An instructional line drawing showing a person's hands holding an ophthalmic solution bottle, with one hand gripping the bottle and the other hand turning the cap, indicating how to open or close the eye drop bottle. The illustration is labeled as Figure - F.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Dorzolamide Hydrochloride showing its molecular arrangement including sulfur, oxygen, nitrogen atoms, and hydrochloride group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.